| PERIOD ENDING | 30-Jun-07 | 31-Mar-07 | 31-Dec-06 | 30-Sep-06 | | Total Revenue | 1,438,405 | 1,386,155 | 1,376,652 | 1,340,081 | | Cost of Revenue | 299,186 | 290,025 | 297,773 | 291,222 | | | Gross Profit | 1,139,219 | 1,096,130 | 1,078,879 | 1,048,859 | | | Operating Expenses | | Research Development | (18,781) | 18,781 |
-
|
-
| | Selling General and Administrative | 583,038 | 522,905 | 551,181 | 534,473 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 38,305 | 28,429 | 49,051 | 22,395 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 536,657 | 526,015 | 478,647 | 491,991 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 536,657 | 526,015 | 478,647 | 491,991 | | Interest Expense | 206,330 | 198,674 | 182,768 | 176,581 | | Income Before Tax | 330,327 | 327,341 | 295,879 | 315,410 | | Income Tax Expense | 110,038 | 110,579 | 90,522 | 103,446 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 220,289 | 216,762 | 205,357 | 211,964 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 220,289 | 216,762 | 205,357 | 211,964 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $220,289 | $216,762 | $205,357 | $211,964 |
|
1.49% Nasdaq 0.00%
Income Statement
